LLMpediaThe first transparent, open encyclopedia generated by LLMs

channelrhodopsin-2

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Edward Boyden Hop 4
Expansion Funnel Raw 60 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted60
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
channelrhodopsin-2
NameChannelrhodopsin-2
OrganismChlamydomonas reinhardtii
UniProtQ2QCJ4

channelrhodopsin-2 is a light-gated ion channel protein originally discovered in the unicellular green alga Chlamydomonas reinhardtii. It functions as a sensory photoreceptor, allowing the organism to move toward light in a process known as phototaxis. When expressed in neurons, it enables precise, millisecond-timescale control of action potential firing with pulses of blue light, forming the foundational molecular tool for the field of optogenetics.

Structure and mechanism

The protein is a seven-transmembrane opsin that binds the chromophore all-trans-retinal. Its structure, elucidated through techniques like X-ray crystallography and cryo-electron microscopy, reveals a central pore formed by transmembrane helices. Upon absorption of a photon of blue light (~470 nm), the retinal isomerizes, triggering a conformational change that opens the cation-conducting pore. This allows a nonspecific influx of cations, primarily sodium ions and protons, down their electrochemical gradient, leading to depolarization of the cell membrane. The kinetics of this photocycle, including rapid opening and slower inactivation, are critical for its utility in neuroscience. Key residues, such as glutamate 123, have been identified as crucial for proton transport and channel gating.

Discovery and development

The protein was first identified and characterized in the laboratory of Peter Hegemann and Georg Nagel in the early 2000s, building upon earlier work on algal photoreceptors by researchers like Kenneth W. Foster. In 2005, a landmark paper by Karl Deisseroth, Edward S. Boyden, and Feng Zhang demonstrated that heterologous expression of the channelrhodopsin-2 gene in mammalian neurons enabled reliable optical control of action potential firing. This publication, alongside contemporaneous work from Gero Miesenböck, is widely credited with launching the modern field of optogenetics. The gene was subsequently codon-optimized for expression in various model organisms, including mice, rats, and fruit flies.

Applications in optogenetics

As the first reliable single-component optogenetic actuator, it revolutionized systems neuroscience by allowing causal interrogation of specific neural circuits with unprecedented temporal precision. Researchers use viral vectors, such as those based on adeno-associated virus, to deliver the gene under the control of cell type-specific promoters like CaMKII or Thy1. This enables experiments where light stimulation of defined neuronal populations can elicit or suppress behaviors in organisms from Caenorhabditis elegans to non-human primates. Its application extends beyond basic research, with exploratory use in vision restoration strategies, such as in models of retinitis pigmentosa, and in dissecting the circuitry underlying Parkinson's disease, anxiety, and addiction.

Variants and engineered forms

Extensive protein engineering has created a suite of variants with altered properties. Key developments include ChETA, developed in the Deisseroth Lab, which has faster kinetics for driving high-frequency action potential trains. Red-shifted variants like Chrimson, from the Boyden Lab, allow deeper tissue penetration and multiplexing with other optogenetic tools. Gain-of-function mutations, such as the H134R substitution, increase photocurrent magnitude. Other engineered forms exhibit altered ion selectivity, slower kinetics, or enhanced membrane trafficking. These variants are often disseminated through repositories like Addgene and have been incorporated into comprehensive toolkits alongside archaerhodopsin inhibitors and genetically encoded calcium indicators.

Limitations and challenges

Primary limitations include its activation by blue light, which has poor tissue penetration and can cause phototoxicity. The requirement for exogenous retinal supplementation in some animal models can be a constraint. High-level expression may lead to cytotoxicity or cellular stress. There are also challenges in achieving uniform, high-density expression across large brain volumes, often requiring complex optical interfaces like fiber optic cannulas or integrated circuit-based micro-LED arrays. Furthermore, the inherent biophysics of the channel, including its desensitization and precise spectral sensitivity, can complicate certain experimental designs, driving continued development of next-generation tools beyond the native protein.

Category:Optogenetics Category:Ion channels Category:Opsins